Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and caffeic acid phenethyl ester

erlotinib hydrochloride has been researched along with caffeic acid phenethyl ester in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(caffeic acid phenethyl ester)		Trials
(caffeic acid phenethyl ester)		Recent Studies (post-2010) (caffeic acid phenethyl ester)
4,3537863,0338401469

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)caffeic acid phenethyl ester (IC50)
Aldo-keto reductase family 1 member B10Homo sapiens (human)0.1833
Epidermal growth factor receptorHomo sapiens (human)1.005
Estrogen receptorHomo sapiens (human)7.912
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)1.329
Tyrosine-protein kinase LckHomo sapiens (human)2.887
Tyrosine-protein kinase FynHomo sapiens (human)4.214
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)3.787
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)0.97
Aldo-keto reductase family 1 member B1Homo sapiens (human)2.065
Polyunsaturated fatty acid lipoxygenase ALOX15Homo sapiens (human)0.13
Aldo-keto reductase family 1 member C4Homo sapiens (human)5.275
Prostaglandin G/H synthase 1Homo sapiens (human)0.833
Sodium-dependent noradrenaline transporter Homo sapiens (human)3.787
Mitogen-activated protein kinase 1Homo sapiens (human)0.686
Aldo-keto reductase family 1 member C3Homo sapiens (human)2.705
Aldo-keto reductase family 1 member C2 Homo sapiens (human)6
Integrase Human immunodeficiency virus 18.0265

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kaul, SC; Kumar, V; Malik, V; Sundar, D; Wadhwa, R1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and caffeic acid phenethyl ester

ArticleYear
Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers.
    Biomolecules, 2021, 01-26, Volume: 11, Issue:2

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Caffeic Acids; Computational Biology; Computer Simulation; Dimerization; ErbB Receptors; Erlotinib Hydrochloride; Exons; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Indolizines; Ligands; Lung Neoplasms; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Phenylethyl Alcohol; Quinazolines; Withanolides

2021